Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV Antiretroviral Drugs and Metabolism.

Trial Profile

HIV Antiretroviral Drugs and Metabolism.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ritonavir (Primary) ; Atazanavir; Efavirenz; Lopinavir/ritonavir
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Jun 2010 Results of ritonavir effects on insulin sensitivity have been published in the Journal of Acquired Immune Deficiency Syndromes.
    • 09 Oct 2009 Planned number of patients (60) added as reported by ClinicalTrials.gov.
    • 27 Dec 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top